STOCK TITAN

[Form 4] The Charles Schwab Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Director Stephen A. Ellis of Charles Schwab executed notable insider transactions on June 24, 2025:

  • Exercised 1,853 nonqualified stock options at a strike price of $33.12 per share
  • Acquired 1,853 shares of common stock through option exercise
  • Contributed the newly acquired shares plus additional 2,379 shares to a revocable trust

Following these transactions, Ellis's holdings include:

  • 6,660 shares held directly
  • 93,389 shares held indirectly through trust (including 304 shares from dividend reinvestment)

The stock options were granted under the Directors' Deferred Compensation Plan II with immediate vesting and were set to expire on July 1, 2025. This Form 4 filing was submitted by attorney-in-fact P. Blake Allen on June 26, 2025.

Il direttore Stephen A. Ellis di Charles Schwab ha effettuato importanti operazioni di insider trading il 24 giugno 2025:

  • Ha esercitato 1.853 opzioni su azioni non qualificate con un prezzo di esercizio di 33,12 $ per azione
  • Ha acquisito 1.853 azioni ordinarie tramite l'esercizio delle opzioni
  • Ha conferito le azioni appena acquisite più ulteriori 2.379 azioni a un trust revocabile

Dopo queste operazioni, le partecipazioni di Ellis includono:

  • 6.660 azioni detenute direttamente
  • 93.389 azioni detenute indirettamente tramite trust (inclusi 304 azioni derivanti da reinvestimento di dividendi)

Le opzioni su azioni sono state concesse nell'ambito del Directors' Deferred Compensation Plan II con maturazione immediata e scadranno il 1° luglio 2025. Questa comunicazione Form 4 è stata presentata dall’avvocato rappresentante P. Blake Allen il 26 giugno 2025.

El director Stephen A. Ellis de Charles Schwab realizó transacciones internas destacadas el 24 de junio de 2025:

  • Ejerció 1,853 opciones sobre acciones no calificadas a un precio de ejercicio de $33.12 por acción
  • Adquirió 1,853 acciones ordinarias mediante el ejercicio de opciones
  • Contribuyó las acciones recién adquiridas más otras 2,379 acciones a un fideicomiso revocable

Tras estas transacciones, las participaciones de Ellis incluyen:

  • 6,660 acciones en propiedad directa
  • 93,389 acciones en propiedad indirecta a través del fideicomiso (incluyendo 304 acciones provenientes de reinversión de dividendos)

Las opciones sobre acciones fueron otorgadas bajo el Directors' Deferred Compensation Plan II con adquisición inmediata y vencen el 1 de julio de 2025. Esta presentación del Formulario 4 fue realizada por el apoderado P. Blake Allen el 26 de junio de 2025.

Charles Schwab의 이사 Stephen A. Ellis2025년 6월 24일에 중요한 내부자 거래를 실행했습니다:

  • 행사가격 $33.12에 1,853개의 비자격 스톡옵션을 행사함
  • 옵션 행사로 1,853주의 보통주를 취득함
  • 취득한 주식과 추가로 2,379주를 취소 가능한 신탁에 출연함

이 거래 이후 Ellis의 보유 주식은 다음과 같습니다:

  • 6,660주 직접 보유
  • 93,389주 신탁을 통한 간접 보유 (배당 재투자 304주 포함)

해당 스톡옵션은 Directors' Deferred Compensation Plan II에 따라 즉시 권리가 부여되었으며 2025년 7월 1일 만료 예정입니다. 이 Form 4 제출은 2025년 6월 26일 대리인 P. Blake Allen에 의해 이루어졌습니다.

Le directeur Stephen A. Ellis de Charles Schwab a réalisé des transactions d'initiés notables le 24 juin 2025 :

  • A exercé 1 853 options d'achat d'actions non qualifiées à un prix d'exercice de 33,12 $ par action
  • A acquis 1 853 actions ordinaires par l'exercice de ces options
  • A transféré les actions nouvellement acquises ainsi que 2 379 actions supplémentaires à une fiducie révocable

À la suite de ces transactions, les avoirs de M. Ellis comprennent :

  • 6 660 actions détenues directement
  • 93 389 actions détenues indirectement via la fiducie (y compris 304 actions issues du réinvestissement des dividendes)

Les options d'achat ont été accordées dans le cadre du Directors' Deferred Compensation Plan II avec acquisition immédiate des droits et expirent le 1er juillet 2025. Ce dépôt du formulaire 4 a été soumis par le mandataire P. Blake Allen le 26 juin 2025.

Direktor Stephen A. Ellis von Charles Schwab führte am 24. Juni 2025 bedeutende Insider-Transaktionen durch:

  • Ausübung von 1.853 nicht qualifizierten Aktienoptionen zu einem Ausübungspreis von 33,12 $ pro Aktie
  • Erwerb von 1.853 Stammaktien durch Ausübung der Optionen
  • Übertragung der neu erworbenen Aktien plus zusätzlich 2.379 Aktien in einen widerruflichen Trust

Nach diesen Transaktionen umfasst Ellis' Bestand:

  • 6.660 direkt gehaltene Aktien
  • 93.389 Aktien, die indirekt über den Trust gehalten werden (einschließlich 304 Aktien aus Dividenden-Reinvestitionen)

Die Aktienoptionen wurden im Rahmen des Directors' Deferred Compensation Plan II mit sofortiger Unverfallbarkeit gewährt und laufen am 1. Juli 2025 ab. Diese Form 4-Meldung wurde am 26. Juni 2025 vom Bevollmächtigten P. Blake Allen eingereicht.

Positive
  • None.
Negative
  • None.

Il direttore Stephen A. Ellis di Charles Schwab ha effettuato importanti operazioni di insider trading il 24 giugno 2025:

  • Ha esercitato 1.853 opzioni su azioni non qualificate con un prezzo di esercizio di 33,12 $ per azione
  • Ha acquisito 1.853 azioni ordinarie tramite l'esercizio delle opzioni
  • Ha conferito le azioni appena acquisite più ulteriori 2.379 azioni a un trust revocabile

Dopo queste operazioni, le partecipazioni di Ellis includono:

  • 6.660 azioni detenute direttamente
  • 93.389 azioni detenute indirettamente tramite trust (inclusi 304 azioni derivanti da reinvestimento di dividendi)

Le opzioni su azioni sono state concesse nell'ambito del Directors' Deferred Compensation Plan II con maturazione immediata e scadranno il 1° luglio 2025. Questa comunicazione Form 4 è stata presentata dall’avvocato rappresentante P. Blake Allen il 26 giugno 2025.

El director Stephen A. Ellis de Charles Schwab realizó transacciones internas destacadas el 24 de junio de 2025:

  • Ejerció 1,853 opciones sobre acciones no calificadas a un precio de ejercicio de $33.12 por acción
  • Adquirió 1,853 acciones ordinarias mediante el ejercicio de opciones
  • Contribuyó las acciones recién adquiridas más otras 2,379 acciones a un fideicomiso revocable

Tras estas transacciones, las participaciones de Ellis incluyen:

  • 6,660 acciones en propiedad directa
  • 93,389 acciones en propiedad indirecta a través del fideicomiso (incluyendo 304 acciones provenientes de reinversión de dividendos)

Las opciones sobre acciones fueron otorgadas bajo el Directors' Deferred Compensation Plan II con adquisición inmediata y vencen el 1 de julio de 2025. Esta presentación del Formulario 4 fue realizada por el apoderado P. Blake Allen el 26 de junio de 2025.

Charles Schwab의 이사 Stephen A. Ellis2025년 6월 24일에 중요한 내부자 거래를 실행했습니다:

  • 행사가격 $33.12에 1,853개의 비자격 스톡옵션을 행사함
  • 옵션 행사로 1,853주의 보통주를 취득함
  • 취득한 주식과 추가로 2,379주를 취소 가능한 신탁에 출연함

이 거래 이후 Ellis의 보유 주식은 다음과 같습니다:

  • 6,660주 직접 보유
  • 93,389주 신탁을 통한 간접 보유 (배당 재투자 304주 포함)

해당 스톡옵션은 Directors' Deferred Compensation Plan II에 따라 즉시 권리가 부여되었으며 2025년 7월 1일 만료 예정입니다. 이 Form 4 제출은 2025년 6월 26일 대리인 P. Blake Allen에 의해 이루어졌습니다.

Le directeur Stephen A. Ellis de Charles Schwab a réalisé des transactions d'initiés notables le 24 juin 2025 :

  • A exercé 1 853 options d'achat d'actions non qualifiées à un prix d'exercice de 33,12 $ par action
  • A acquis 1 853 actions ordinaires par l'exercice de ces options
  • A transféré les actions nouvellement acquises ainsi que 2 379 actions supplémentaires à une fiducie révocable

À la suite de ces transactions, les avoirs de M. Ellis comprennent :

  • 6 660 actions détenues directement
  • 93 389 actions détenues indirectement via la fiducie (y compris 304 actions issues du réinvestissement des dividendes)

Les options d'achat ont été accordées dans le cadre du Directors' Deferred Compensation Plan II avec acquisition immédiate des droits et expirent le 1er juillet 2025. Ce dépôt du formulaire 4 a été soumis par le mandataire P. Blake Allen le 26 juin 2025.

Direktor Stephen A. Ellis von Charles Schwab führte am 24. Juni 2025 bedeutende Insider-Transaktionen durch:

  • Ausübung von 1.853 nicht qualifizierten Aktienoptionen zu einem Ausübungspreis von 33,12 $ pro Aktie
  • Erwerb von 1.853 Stammaktien durch Ausübung der Optionen
  • Übertragung der neu erworbenen Aktien plus zusätzlich 2.379 Aktien in einen widerruflichen Trust

Nach diesen Transaktionen umfasst Ellis' Bestand:

  • 6.660 direkt gehaltene Aktien
  • 93.389 Aktien, die indirekt über den Trust gehalten werden (einschließlich 304 Aktien aus Dividenden-Reinvestitionen)

Die Aktienoptionen wurden im Rahmen des Directors' Deferred Compensation Plan II mit sofortiger Unverfallbarkeit gewährt und laufen am 1. Juli 2025 ab. Diese Form 4-Meldung wurde am 26. Juni 2025 vom Bevollmächtigten P. Blake Allen eingereicht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ellis Stephen A

(Last) (First) (Middle)
3000 SCHWAB WAY

(Street)
WESTLAKE TX 76262

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SCHWAB CHARLES CORP [ SCHW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/24/2025 M 1,853 A $33.12 6,660(1) D
Common Stock 93,389.6514(1)(2) I by Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Nonqualified Stock Option (right to buy) $33.12 06/24/2025 M 1,853 (3) 07/01/2025 Common Stock 1,853 $0 0 D
Explanation of Responses:
1. Reflects the contribution of shares received upon exercise of the option and 2,379.1115 other shares to a revocable trust.
2. Includes 304.2606 shares acquired through dividend reinvestment.
3. The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately.
Remarks:
/s/ P. Blake Allen, Attorney-in-fact 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider trading activity occurred at Charles Schwab (SCHW) on June 24, 2025?

Director Stephen A. Ellis exercised 1,853 nonqualified stock options at a strike price of $33.12 per share, acquiring the same number of common shares. These shares were subsequently contributed to a revocable trust.

How many shares does SCHW Director Stephen Ellis own after the June 2025 transaction?

After the transaction, Stephen Ellis beneficially owns 100,049.6514 shares total, consisting of 6,660 shares held directly and 93,389.6514 shares held indirectly through a trust. The trust holdings include shares from the recent option exercise and 304.2606 shares acquired through dividend reinvestment.

What was the exercise price of SCHW stock options exercised by Director Ellis?

The nonqualified stock options were exercised at a price of $33.12 per share. These options were originally received under the Directors' Deferred Compensation Plan II and were set to expire on July 1, 2025.

When do Stephen Ellis's remaining SCHW stock options expire?

After this transaction, Stephen Ellis has no remaining stock options, as the Form 4 shows that following the exercise of 1,853 options, the number of derivative securities beneficially owned is 0.
Schwab (CHARLES) Corp. (The)

NYSE:SCHW

SCHW Rankings

SCHW Latest News

SCHW Latest SEC Filings

SCHW Stock Data

162.09B
1.71B
6.34%
76.21%
0.93%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
WESTLAKE